Clinic
Asian Pacific Health Care Venture, INC.
Asian Pacific Health Care Venture, INC. was paid $99K by Medicaid between Jan 2018 and Dec 2024, across 159 billing codes. Its largest line is 90686, — 35% of everything it billed.
33Billing provider infoASIAN PACIFIC HEALTH CARE VENTURE, INC.
LOS ANGELES, CA 90027
LOS ANGELES, CA 90027
33aNPI1407984149assigned 03/02/2007
33bProvider typeCommunity Health Clinic/Center
28Total paid$99K
24GClaims738,321
24DCodes billed159
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#227 of 288
Median peer was paid$2.15M
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,874 | $32K | |
| 2019 | 87,125 | $65K | |
| 2020 | 52,436 | $606.70 | |
| 2021 | 90,176 | $1K | |
| 2022 | 145,449 | $801.80 | |
| 2023 | 178,106 | $289.19 | |
| 2024incomplete | 123,155 | $292.59 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90686 | 35% | 18,548 | 18,541 | $35K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 108,914 | 102,406 | $31K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 5.9% | 7,719 | 7,713 | $6K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.5% | 15,549 | 15,039 | $3K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.2% | 2,601 | 2,597 | $3K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.2% | 3,484 | 3,480 | $2K |
| 90670 | 2.2% | 847 | 847 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.1% | 33,615 | 33,416 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.9% | 2,554 | 2,554 | $2K |
| 92552 | 1.7% | 3,500 | 3,486 | $2K | |
| 90746 | 1.5% | 1,015 | 1,015 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 1,278 | 1,278 | $1K |
147 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.0% | 19,835 | $1K |
| 82948 | <1% | 21,196 | $858.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,191 | $721.14 |
| 90620 | <1% | 92 | $467.00 | |
| 90698 | <1% | 256 | $349.08 | |
| 80061 | Lipid panel | <1% | 34,305 | $337.00 |
| 90715 | <1% | 1,579 | $335.00 | |
| 93000 | <1% | 1,587 | $312.51 | |
| 85018 | <1% | 6,909 | $287.04 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 18,245 | $258.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 34,967 | $258.00 |
| 90651 | <1% | 552 | $242.00 | |
| 80053 | Comprehensive metabolic panel | <1% | 36,692 | $242.00 |
| 90633 | <1% | 629 | $170.73 | |
| 90744 | <1% | 112 | $146.40 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 6,069 | $137.00 |
| 98960 | <1% | 149 | $133.30 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 256 | $114.40 |
| 99385 | <1% | 325 | $112.96 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 620 | $75.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 5,015 | $63.00 |
| 81001 | <1% | 9,946 | $63.00 | |
| 90707 | <1% | 43 | $60.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 998 | $60.00 |
| 86580 | <1% | 317 | $53.28 | |
| 97803 | <1% | 1,276 | $51.96 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 619 | $51.31 |
| 81003 | <1% | 5,292 | $42.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 29,592 | $42.00 |
| 86317 | <1% | 2,361 | $42.00 | |
| 86592 | <1% | 3,831 | $42.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,988 | $42.00 |
| 87340 | <1% | 1,832 | $42.00 | |
| 81002 | <1% | 3,885 | $35.91 | |
| 97802 | <1% | 902 | $30.35 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 133 | $27.68 |
| 1160F | <1% | 52,915 | $24.00 | |
| 83540 | <1% | 1,162 | $21.00 | |
| 86803 | <1% | 2,081 | $21.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 6,353 | $21.00 |
| 86704 | <1% | 1,293 | $21.00 | |
| 90681 | <1% | 29 | $18.00 | |
| 81025 | <1% | 949 | $16.62 | |
| 1159F | 0% | 107,698 | $0.00 | |
| 99173 | 0% | 6,749 | $0.00 | |
| 3078F | 0% | 15,858 | $0.00 | |
| 3077F | 0% | 5,200 | $0.00 | |
| 87338 | 0% | 1,164 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 3,709 | $0.00 |
| 86480 | 0% | 3,286 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 120 | $0.00 |
| 86708 | 0% | 1,026 | $0.00 | |
| 86765 | 0% | 21 | $0.00 | |
| 84439 | 0% | 1,350 | $0.00 | |
| 84550 | 0% | 1,634 | $0.00 | |
| 0124A | 0% | 318 | $0.00 | |
| 82274 | 0% | 3,178 | $0.00 | |
| 80076 | 0% | 1,588 | $0.00 | |
| 0002A | 0% | 141 | $0.00 | |
| 82610 | 0% | 13 | $0.00 | |
| 86003 | 0% | 27 | $0.00 | |
| 91312 | 0% | 353 | $0.00 | |
| 84481 | 0% | 241 | $0.00 | |
| 2022F | 0% | 134 | $0.00 | |
| 82652 | 0% | 306 | $0.00 | |
| 80074 | 0% | 184 | $0.00 | |
| 83655 | 0% | 278 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 598 | $0.00 |
| 90671 | 0% | 143 | $0.00 | |
| 99401 | 0% | 302 | $0.00 | |
| 90734 | 0% | 71 | $0.00 | |
| 11721 | 0% | 36 | $0.00 | |
| 91300 | 0% | 344 | $0.00 | |
| 90662 | 0% | 324 | $0.00 | |
| 85610 | 0% | 159 | $0.00 | |
| 86705 | 0% | 171 | $0.00 | |
| 99397 | 0% | 27 | $0.00 | |
| A4550 | Surgical trays | 0% | 25 | $0.00 |
| 90461 | 0% | 90 | $0.00 | |
| 90685 | 0% | 29 | $0.00 | |
| 96158 | 0% | 13 | $0.00 | |
| 90700 | 0% | 26 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 24 | $0.00 |
| H1003 | Prenatal care, at-risk enhanced service; education | 0% | 35 | $0.00 |
| 82785 | 0% | 13 | $0.00 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 0% | 28 | $0.00 |
| 86735 | 0% | 20 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 16 | $0.00 |
| 90736 | 0% | 12 | $0.00 | |
| 0071A | 0% | 56 | $0.00 | |
| 2024F | 0% | 13 | $0.00 | |
| 90656 | 0% | 2,563 | $0.00 | |
| 83550 | 0% | 1,159 | $0.00 | |
| 84153 | 0% | 603 | $0.00 | |
| 3079F | 0% | 8,719 | $0.00 | |
| 3075F | 0% | 4,827 | $0.00 | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 0% | 2,460 | $0.00 |
| 90688 | 0% | 13 | $0.00 | |
| G0467 | Community health center visit, returning patient | 0% | 578 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 1,600 | $0.00 |
| 0012A | 0% | 450 | $0.00 | |
| 86140 | 0% | 59 | $0.00 | |
| 92551 | 0% | 3,430 | $0.00 | |
| 3074F | 0% | 15,466 | $0.00 | |
| 90619 | 0% | 78 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 3,178 | $0.00 |
| 82728 | 0% | 1,082 | $0.00 | |
| 82043 | 0% | 5,534 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 635 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 2,121 | $0.00 |
| 90647 | 0% | 150 | $0.00 | |
| 0011A | 0% | 441 | $0.00 | |
| 88142 | 0% | 243 | $0.00 | |
| 96156 | 0% | 198 | $0.00 | |
| 3080F | 0% | 968 | $0.00 | |
| 90474 | 0% | 25 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 88 | $0.00 |
| 94760 | 0% | 12 | $0.00 | |
| 90677 | 0% | 255 | $0.00 | |
| 91301 | 0% | 958 | $0.00 | |
| 81015 | 0% | 129 | $0.00 | |
| 90723 | 0% | 141 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 457 | $0.00 |
| 90697 | 0% | 168 | $0.00 | |
| 92250 | 0% | 41 | $0.00 | |
| 0001A | 0% | 153 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
| 90716 | 0% | 14 | $0.00 | |
| 82607 | 0% | 25 | $0.00 | |
| G9012 | Other specified case management service not elsewhere classified | 0% | 80 | $0.00 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 0% | 75 | $0.00 |
| 0064A | 0% | 149 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 303 | $0.00 |
| 91306 | 0% | 67 | $0.00 | |
| 0072A | 0% | 38 | $0.00 | |
| 3072F | 0% | 68 | $0.00 | |
| 91307 | 0% | 114 | $0.00 | |
| 82950 | 0% | 24 | $0.00 | |
| 99000 | 0% | 37 | $0.00 | |
| 85652 | 0% | 30 | $0.00 | |
| 82746 | 0% | 13 | $0.00 | |
| 59430 | 0% | 28 | $0.00 | |
| 99386 | 0% | 12 | $0.00 | |
| 1111F | 0% | 38 | $0.00 | |
| 0031A | 0% | 19 | $0.00 | |
| 91303 | 0% | 18 | $0.00 | |
| 86762 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHIBATA, KAZUE (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Asian Pacific Health Care Venture, INC. | Los Angeles, CA | $54.09M |
| Asian Pacific Health Care Venture, INC. | Los Angeles, CA | $3.24M |
| Asian Pacific Health Care Venture, INC. | Los Angeles, CA | $112K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.